Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Polatuzumab vedotin's trials
GUIDANCE-10
AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL
Polatuzumab Vedotin
Ongoing
Not yet recruiting
Phase 2
Open NCT07594899 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record